REG - GSK PLC - Jideytro positive data for ROS1-positive NSCLC
RNS Number: 5204U GSK PLC 14 September 2026 Issued: 14 September 2026, London UKGSK presents positive registrational data to potentially expand Jideytro (zidesamtinib) to first-line ROS1-positive non-small cell lung cancerGSK plc (LSE/NYSE: GSK) today announced positive results from the r…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.